z-logo
open-access-imgOpen Access
Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients With Chronic Kidney Disease
Author(s) -
Ada W.Y. Chung,
H.H. Clarice Yang,
Jong Moo Kim,
Mhairi K. Sigrist,
Elliott Chum,
William A. Gourlay,
Adeera Levin
Publication year - 2009
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.109.862565
Subject(s) - medicine , kidney disease , dialysis , kidney , renal function , endocrinology , hemodialysis , downregulation and upregulation , transplantation , contractility , arterial stiffness , urology , cardiology , blood pressure , biochemistry , gene , chemistry
Cardiovascular disease is the leading cause of mortality in chronic kidney disease patients on maintenance dialysis. Given the importance of matrix metalloproteinase-2 (MMP-2) in matrix integrity, vascular cell function, and structural stability, we hypothesized that MMP-2 was elevated in the macrovasculature in dialyzed chronic kidney disease patients compared with chronic kidney disease patients not on dialysis and kidney donors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom